Abatacept - HY-108829
Nur noch %1 verfügbar
Catalog #
HY-108829
Ab
541,00 €
Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains)[1]. Abatacept is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases[2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-108829/Abatacept-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Isolate blue ice and the product with bubble pack to avoid direct contact |
| Application | COVID-19-immunoregulation |
| Alternative Names | CTLA4lg; BMS-188667 |
| CAS | 332348-12-6 |
| Storage | Store at 4°C for 2 years, do not freeze |
| MWT | N/A |
| Solubility | H2O |
| Clinical Information | Launched |
| Pathway | Immunology/Inflammation |
| Target | CTLA-4 |
| Application: | COVID-19-immunoregulation |
|---|